36 filings
8-K
TCRX
Tscan Therapeutics Inc
13 May 24
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:15am
8-K
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
8-K
TCRX
Tscan Therapeutics Inc
16 Apr 24
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
4:16pm
8-K
TCRX
Tscan Therapeutics Inc
8 Apr 24
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert
8:17am
8-K
TCRX
Tscan Therapeutics Inc
6 Mar 24
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:15am
8-K
elhr0cgxny96zddl4 cj
29 Jan 24
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
7:15am
8-K
62xev465 3ihw90dsih
11 Dec 23
Regulation FD Disclosure
8:00am
8-K
sjy5oxu
7 Dec 23
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
7:15am
8-K
2u5g0fokol9 z3p
9 Nov 23
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
7pyzzden95 97r
10 Aug 23
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
vwf20thxdgydx6 zbq
24 Jul 23
Departure of Directors or Certain Officers
7:24pm
8-K
i6jc48oc1foxmqqpo0
29 Jun 23
TScan Therapeutics Announces Transition of Chief Financial Officer
8:30am
8-K
yrvo3yf3
15 Jun 23
Departure of Directors or Certain Officers
5:37pm
8-K
inuuizsauq 84em
31 May 23
TScan Therapeutics Announces Launch of Proposed Public Offering
8:16am
8-K
rpb3j2ki52aknzfkmmz
31 May 23
TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors
8:00am
8-K
21gmii2mo0utzmdgq1
17 May 23
Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transplantation
8:15am
8-K
5t2msu66ef h94skcc
16 May 23
Other Events
5:21pm
8-K
1b27d4pbu hhlxy
10 May 23
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:16am
8-K
s1r7j9
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
8-K
3ubx3rgl6iq2
10 Apr 23
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
7:45am